Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Mark E. Delaney

At a glance: Mark E. Delaney is Svp & Chief Commercial Officer at Quest Diagnostics (DGX). Their latest SEC Form 4, filed Jul 29, 2026, reported a sale of $376K. On file: 0 purchase lines ($0) and 2 sale lines ($1.9M).

Disclosed holdings: about $2.7M of DGX stock: 10,335 shares reported on their latest Form 4 (filed Jul 29, 2026), valued at the Nov 19, 2026 close of $259.06. This counts only DGX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Svp & Chief Commercial Officer at Quest Diagnostics Inc (DGX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M

Mark E. Delaney's InsiderPrint

2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Mark E. Delaney: 2 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 1 sale
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Jul 29SEC DGXQuest Diagnostics Inc Sell Plan 1,60010,335 held (−13%) $235.18 $376K +10.2%
Nov 20SEC DGXQuest Diagnostics Inc Sell Plan 7,9467,530 held (−51%) $187.35 $1.5M +38.3%
  • Sell

    Svp & Chief Commercial Officer Mark E Delaney sold $376K of DGX at $235.18 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp & Chief Commercial Officer Mark E Delaney sold $1.5M of DGX at $187.35 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.

Follow Mark E. Delaney

Get one email when Mark E. Delaney files a new purchase or sale. Free.

At most one email a day about Mark E. Delaney, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.